Holen Sie sich die Stockscreener-App
0.346
11.28%
-0.044
Handel nachbörslich:
.35
0.004
+1.16%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$0.39
Offen:
$0.387
24-Stunden-Volumen:
920.27K
Relative Volume:
0.10
Marktkapitalisierung:
$10.46M
Einnahmen:
$62.71M
Nettoeinkommen (Verlust:
$-10.48M
KGV:
-0.5492
EPS:
-0.63
Netto-Cashflow:
$-13.77M
1W Leistung:
-24.78%
1M Leistung:
-17.05%
6M Leistung:
-85.58%
1J Leistung:
-94.77%
1-Tages-Spanne:
$0.3435
$0.40
1-Wochen-Bereich:
$0.3435
$0.52
52-Wochen-Spanne:
$0.2179
$7.48
Prophase Labs Inc Stock (PRPH) Company Profile
Firmenname
Prophase Labs Inc
Sektor
Branche
Telefon
(215) 345-0919
Adresse
711 STEWART AVE, SUITE 200, NEW YORK, PA
Vergleichen Sie PRPH mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PRPH
Prophase Labs Inc
|
0.346 | 10.46M | 62.71M | -10.48M | -13.77M | -0.63 |
|
TMO
Thermo Fisher Scientific Inc
|
470.03 | 177.32B | 42.88B | 6.34B | 7.27B | 16.53 |
|
DHR
Danaher Corp
|
197.90 | 141.59B | 23.88B | 3.90B | 5.30B | 5.28 |
|
IDXX
Idexx Laboratories Inc
|
410.76 | 33.29B | 3.90B | 887.87M | 798.08M | 10.67 |
|
A
Agilent Technologies Inc
|
109.67 | 31.28B | 6.53B | 1.26B | 1.31B | 4.35 |
|
IQV
Iqvia Holdings Inc
|
167.69 | 29.57B | 15.41B | 1.37B | 2.11B | 7.50 |
Prophase Labs Inc Stock (PRPH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2021-12-20 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-10-13 | Herabstufung | Dawson James | Buy → Neutral |
| 2021-01-20 | Eingeleitet | Dawson James | Buy |
Prophase Labs Inc Aktie (PRPH) Neueste Nachrichten
ProPhase Labs Inc (PRPH) Q4 2024 Earnings Call Highlights: Strategic Moves and Financial Challenges - Yahoo Finance
A Tale of Resilience: ProPhase Labs Inc Amid Stock Market Turbulence - investchronicle.com
ProPhase Labs Delays Yearly Report Filing - TipRanks
ProPhase Labs, Inc. (NASDAQ:PRPH) Q4 2024 Earnings Call Transcript - Insider Monkey
Prophase Labs Inc reports results for the quarter ended December 31Earnings Summary - TradingView
ProPhase Labs, Inc. SEC 10-K Report - TradingView
ProPhase Labs Reports 2024 Financial Results and Strategic Shift - TipRanks
Earnings call transcript: ProPhase Labs Q4 2024 earnings miss, stock falls By Investing.com - Investing.com Australia
ProPhase Labs earnings missed by $1.62, revenue topped estimates - Investing.com Canada
Earnings call transcript: ProPhase Labs Q4 2024 earnings miss, stock falls - Investing.com
ProPhase Labs Inc Reports $6.8 Million Revenue and $(2.61) EPS f - GuruFocus
ProPhase Labs, Inc. Announces Financial Results for the Year Ended December 31, 2024 - The Manila Times
ProPhase Labs Pivots Business Model After $53M Loss: Cancer Test Launch Takes Center Stage - Stock Titan
ProPhase Labs (PRPH) Set to Announce FY Earnings, Faces Challenges - GuruFocus.com
An Overview of ProPhase Labs's Earnings - Benzinga
ProPhase Labs Inc. to Present 2024 Year End Financial Results on March 31, 2025 - The Manila Times
ProPhase Labs Announces Key Full Year 2024 Financial Results PresentationVirtual Access Available - Stock Titan
ProPhase Labs (PRPH) Projected to Post Earnings on Thursday - Defense World
ProPhase Labs, Inc. CEO Ted Karkus to Present at Q1 Investor Summit Virtual on March 11th - Nasdaq
ProPhase Labs to Present at the Investor Summit Virtual on March 11 - GlobeNewswire
Can ProPhase Labs Convince Investors? CEO Reveals Strategic Vision Next Week - StockTitan
Bears are Losing Control Over ProPhase Labs (PRPH), Here's Why It's a 'Buy' Now - Yahoo Finance
ProPhase Labs, Inc. to Host Earnings Call - ACCESS Newswire
Diamond Equity Research Releases Update Note on ProPhase Labs Inc. (NASDAQ: PRPH) - EIN News
Deeper Dive: Understanding ProPhase Labs Inc (PRPH) Through its Various Ratios - The Dwinnex
ProPhase Labs Examines Strategic Opportunities to Leverage - GlobeNewswire
ProPhase Labs Focuses On Telehealth And DTC Marketing For Prescription Drug Growth Strategy - Nasdaq
ProPhase Labs examines opportunities to leverage DTC multi-media infrastructure - TipRanks
ProPhase Labs Examines Strategic Opportunities to Leverage Its DTC Multi-Media Infrastructure with Telehealth Physician Networks for Prescription Drugs - The Manila Times
Can ProPhase's Telehealth Pivot Save Its Stock From Delisting? Company Says No Reverse Split Needed - StockTitan
ProPhase Labs (NASDAQ:PRPH) Now Covered by Analysts at StockNews.com - Defense World
ProPhase sharpens focus on direct-to-consumer growth - Investing.com
ProPhase Labs Appoints Stuart Hollenshead as COO - TipRanks
ProPhase Labs Announces Excellent Progress with Crown - GlobeNewswire
ProPhase Labs Targets Immediate Cash Generation With COVID-19 Receivables And Asset Sales - Nasdaq
Can ProPhase Labs Transform $150M in COVID Claims into a $50M Windfall? - StockTitan
ProPhase Labs Announces Excellent Progress with Crown Medical Collections Targeting Over $50 Million in Net Near-Term Cash Recovery from COVID-19 Receivables - The Manila Times
ProPhase Labs hires former Barstool Sports COO Stuart Hollenshead, plans cost-cutting measures - MSN
ProPhase Labs hires Stuart Hollenshead as COO - TipRanks
ProPhase Labs appoints Stu Hollenshead as COO By Investing.com - Investing.com Nigeria
ProPhase Labs hires Stuart Hollenshead as COO, the former COO and CBO of Barstool Sports - GlobeNewswire
ProPhase Labs Appoints Stu Hollenshead as Chief Operating Officer -February 18, 2025 at 09:45 am EST - Marketscreener.com
ProPhase Labs shares rise on cost cutting plans, hires former Barstool Sports COO Stu Hollenshead - Seeking Alpha
ProPhase Labs appoints Stu Hollenshead as COO - Investing.com
Barstool Sports Executive Powerhouse Joins ProPhase Labs: Major Push into 70M Women Health Market - StockTitan
ProPhase Labs FY2024 EPS Estimate Reduced by Diamond Equity - Defense World
ProPhase Labs (NASDAQ:PRPH) Now Covered by StockNews.com - Defense World
ProPhase Labs Stock Hits 52-Week Low at $0.56 Amid Market Struggles - MSN
ProPhase Labs Appoints New Chief Operating Officer - TipRanks
ProPhase Labs appoints new COO amid executive changes By Investing.com - Investing.com South Africa
ProPhase Labs appoints new COO amid executive changes - MSN
Finanzdaten der Prophase Labs Inc-Aktie (PRPH)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.14%
1.59%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):